|
ZNF77 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.817200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.727400E-01 |
| Normal-vs-Stage2 |
1.430750E-01 |
| Normal-vs-Stage3 |
3.412800E-01 |
| Normal-vs-Stage4 |
3.596200E-03 |
| Stage1-vs-Stage2 |
6.194800E-01 |
| Stage1-vs-Stage3 |
7.827800E-01 |
| Stage1-vs-Stage4 |
1.282240E-02 |
| Stage2-vs-Stage3 |
8.534400E-01 |
| Stage2-vs-Stage4 |
2.748800E-01 |
| Stage3-vs-Stage4 |
3.389000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.804200E-01 |
| Normal-vs-AfricanAmerican |
5.490400E-01 |
| Normal-vs-Asian |
4.578400E-01 |
| Caucasian-vs-AfricanAmerican |
6.166600E-01 |
| Caucasian-vs-Asian |
8.537000E-01 |
| AfricanAmerican-vs-Asian |
7.395000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.392800E-01 |
| Normal-vs-Female |
8.295000E-01 |
| Male-vs-Female |
1.641550E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.060400E-01 |
| Normal-vs-Extreme_Weight |
3.447200E-01 |
| Normal-vs-Obese |
1.939970E-01 |
| Normal-vs-Extreme_Obese |
2.853600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.841600E-01 |
| Normal_Weight-vs-Obese |
8.182200E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.425000E-01 |
| Extreme_Weight-vs-Obese |
7.357600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.722800E-01 |
| Obese-vs-Extreme_Obese |
7.740000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.769200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.628000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.804190E-01 |
| Normal-vs-Age(81-100Yrs) |
2.535300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.302200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.289370E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.824400E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.288200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.557600E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.223900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.237200E-01 |
| Normal-VS-Type2 PRCC |
5.150700E-04 |
| Normal-VS-KIRP CIMP |
4.476400E-01 |
| Normal-VS-Unclassified PRCC |
8.726800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.2878000000004E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.663600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.410600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.270990E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.049000E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
5.539800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.770260E-02 |
| Normal-vs-N1 |
8.544800E-01 |
| Normal-vs-N2 |
2.309700E-02 |
| N0-vs-N1 |
1.017590E-01 |
| N0-vs-N2 |
1.656560E-01 |
| N1-vs-N2 |
1.319160E-01 |
|
|
